期刊论文详细信息
Molecular Medicine | |
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients | |
Zhibin Han1  Zhenfeng Jiang1  Zhiguo Lin1  Xingbo Cheng1  Wang Zhang1  Zhishuai Ren2  Bo Zhang2  Xiaoyu Lian2  Lu Bian2  Jialin Wang2  Hongbo Wang2  Yanbiao Wang2  Binfeng Liu2  Yanzheng Gao3  Zhendong Liu3  | |
[1] Department of Neurosurgery, The First Affiliate Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, 150001, Harbin, China;Department of Orthopaedics, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, China;Department of Orthopaedics, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, China;Microbiology Laboratory, Henan Provincial People’s Hospital, Zhengzhou, China; | |
关键词: Glioma; XRCC2; Oncogene; Prognosis; Biomarker; | |
DOI : 10.1186/s10020-021-00316-0 | |
来源: Springer | |